まとめ
ラテンアメリカ人の遺伝子研究により,新しい2型糖尿病リスク遺伝子SLC16A11.11が発見されました. ネアンデルタール人のDNAに関連したこの遺伝子は,脂質代謝とトリアシルグリセロールレベルに影響を与え,疾患の起源と格差の洞察を提供します.
科学分野:
- 遺伝学 遺伝学とは
- 人口遺伝学 人口遺伝学
- メタボリック障害 メタボリック障害
背景:
- 多様なヒト集団を対象とした遺伝学的研究は,集団特有の疾患リスクアレルを発見することができます.
- これらのアレルを理解することは,疾患の病理生理学と健康の格差を明らかにするために非常に重要です.
研究 の 目的:
- メキシコとラテンアメリカの人口における2型糖尿病に関連した新しい遺伝的位置を特定する.
- 特定されたリスクアレルの進化的起源と機能的影響を調査する.
主な方法:
- 8,214人の個体 (3,848人の2型糖尿病患者,4,366人の対照群) で,9,200万個の単一ヌクレオチドポリモルフィズム (SNP) を対象とした全ゲノム関連研究 (GWAS).
- 独立したサンプルでの複製分析.
- 添加物のための古典的なゲノム配列の分析.
- メッセンジャーRNA (mRNA) と肝臓と異質細胞におけるタンパク質発現の研究.
- 脂質代謝におけるSLC16A11の機能分析.
主要な成果:
- SLC16A11とSLC16A13.3を網羅した,全ゲノムにわたる有意性で,新しい2型糖尿病リスクロカスが特定されました.
- リスクアレルは, ~50%のネイティブアメリカンサンプルに存在し,タイプ2糖尿病の若い,より痩せた個体ではより強い関連性を示しました.
- 古代のゲノム解析は,リスクハプロタイプのネアンデルタール人の侵入を示唆した.
- 肝細胞におけるSLC16A11発現は,脂質代謝を変化させ,細胞内トリアシルグリセロールレベルを上昇させた.
結論:
- SLC16A11は,ラテンアメリカの人口における2型糖尿病の新規候補遺伝子である.
- 特定されたリスクアレルは古代の起源を持ち,ネアンデルタール人から侵入した可能性がある.
- SLC16A11はトライシルグリセロールの代謝に作用し,2型糖尿病の病理生理学に貢献する可能性がある.
さらに関連する動画
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
35.1K
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.5K
関連する概念動画
Comparing Copy Number Variations and SNPs
19.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.4K
Glucose Transporters
28.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K
Diabetes Mellitus: Overview and Type I Subtype
6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
154
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
154
Pathophysiology of Diabetes
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
